The Future of Skin Rejuvenation: From "Filling" to "Self-Repair" With Regenerative Medicine
Why the Beauty Industry Is Talking About "Regenerative Medicine"
For years, skin care and anti-aging have revolved around two main concepts: "Filling," such as injecting filler to add volume, and "Lifting," such as thread lifting or lifting procedures. But a third direction gaining increasing attention among both physicians and patients is "Regenerating" — stimulating the skin to repair itself through genuine biological mechanisms, rather than relying solely on external filling agents.
A review article from a research team at the University of the Ryukyus, Japan, published in Regenerative Therapy in 2022, compiled detailed knowledge on this approach. Mor Pun wants to walk through this together.
Why Conventional Treatments Have Limitations
Familiar treatments such as Hyaluronic Acid Filler, Botulinum Toxin, Topical Growth Factors, Retinoids, and Vitamin C can genuinely help reduce the appearance of wrinkles. However, a key limitation is that results are temporary, since injected substances are gradually absorbed by the body over time, meaning they cannot truly reverse skin aging. There are also risks of complications, such as vascular occlusion, infection, or allergic reactions — factors that have pushed the medical field to look for new approaches that work with the body's own natural repair mechanisms instead.
Regenerative Medicine Divides Into Two Main Categories
The first is Cell-based Therapy, which uses cells directly for treatment, such as Mesenchymal Stem Cells (MSCs), fibroblasts, melanocytes, and Platelet Rich Plasma (PRP).
The second is Cell-free Therapy, which doesn't use cells directly but instead uses substances secreted by cells, such as exosomes, conditioned media, and extracellular vesicles. This research indicates that cell-free therapy is gaining popularity, since it reduces the limitations of direct cell use, both in terms of the complexity of cell collection processes and associated risks.
Mesenchymal Stem Cells (MSCs): The Star of This Research
MSCs can be collected from multiple sources in the body, including adipose tissue, bone marrow, umbilical cord, menstrual blood, endometrium, fetal dermis, and reprogrammed cells like iPSC-derived MSC.
Key properties of MSCs include self-renewal, multipotent differentiation, anti-inflammatory properties, immune system regulation, stimulation of new blood vessel formation (angiogenesis), stimulating fibroblast activity, stimulating collagen synthesis, and reducing scar formation.
Among all MSC types, Adipose-derived MSC (ADMSC) has the most supporting research, thanks to ease of collection, abundance, and good proliferation ability. Key mechanisms of ADMSC include increasing collagen, increasing elastin, increasing new blood vessel formation, restoring elastic fibers, reducing inflammation, and increasing skin elasticity. Clinical trials have reported improvements in skin quality and wrinkles, particularly when used together with hyaluronic acid.
Bone Marrow MSC has the advantage of high differentiation capacity and good angiogenesis stimulation, but has the disadvantage of being harder to collect with lower cell yield, making it better suited for wound treatment, burns, and scars rather than cosmetic use alone.
Umbilical Cord MSC stands out for its high anti-inflammatory properties, helping increase VEGF and Type I and III collagen. Research in burn wounds found it helps wounds heal faster and reduces inflammation effectively.
Endometrial or Menstrual Stem Cells and iPSC remain in the research and development stage but hold high potential for the future. iPSC is considered a future technology capable of producing various cell types from reprogrammed stem cells, though it still faces significant cost and process-complexity limitations today.
Fibroblast Therapy: The Cells That Build Collagen
Fibroblasts are cells responsible for producing collagen, elastin, and the extracellular matrix structure. As we age, the number and efficiency of fibroblasts decline, causing skin to thin and wrinkles to form. One approach involves culturing a patient's own fibroblasts and injecting them back into the skin, which helps boost extracellular matrix structure and reduce wrinkles. In the United States, a product called LAVIV® was once approved for treating nasolabial folds, and this approach is currently used in Japan under the regenerative medicine framework as well.
PRP: The Regenerative Medicine Already Widely Used in Practice
PRP, or Platelet Rich Plasma, is another form of regenerative medicine that is already the most widely used in actual practice. Key substances it releases include PDGF, VEGF, TGF-β, IGF, and FGF, which stimulate fibroblasts, increase Type I collagen, increase new blood vessel formation, and stimulate subcutaneous fat formation. In Japan, PRP for treating wrinkles and skin elasticity is classified as low-risk (Class III) under the country's regulations.
Exosomes: The Rising Star of Cell-Free Therapy
This research places significant emphasis on exosomes, because they can produce results similar to using MSCs directly, without needing to inject cells into the body — significantly reducing complexity and regulatory constraints.
Exosomes help increase fibroblast proliferation, increase keratinocyte migration, increase collagen, reduce oxidative stress, reduce inflammation, reduce UV damage, increase ceramide, and strengthen the skin barrier — making them an approach receiving significant attention in the beauty industry today.
Another interesting piece of research found that using exosomes together with microneedling technique improved wrinkles, improved acne scars, improved skin elasticity, and clearly increased collagen — since microneedling helps deliver substances into the skin more effectively.
Overview Summary of Each Therapy
Based on the full literature review, PRP is the therapy with the strongest supporting evidence and is already widely used in practice. Fibroblast therapy has good supporting evidence and is used in practice in some countries. Adipose MSC has good supporting evidence and is used in specialized clinics. Umbilical Cord MSC and Exosome are still expanding their research base. iPSC remains a future technology awaiting further development.
A Point Mor Pun Wants to Emphasize
This research supports an important concept: the future direction of beauty care is shifting from temporary "filling" toward "regenerating" skin quality through the body's own biological mechanisms. However, it's important for everyone to understand that while regenerative medicine holds high potential and a satisfactory level of safety according to research reports, it remains a field requiring additional long-term clinical evidence, along with clearer manufacturing standards and regulations, before it can be widely adopted. Choosing any approach should always be under the assessment and care of a specialist physician who thoroughly understands the research data.
Closing Summary
Regenerative medicine is a direction well worth watching for the future of skin care and anti-aging, with mechanisms aimed at stimulating the body to repair itself through collagen production, reduced inflammation, new blood vessel formation, and immune system regulation. While clinical evidence and manufacturing standards still need further development today, this direction reflects that the future of beauty may no longer rest solely on filling or lifting alone.